EARLY ACCESS PROGRAM

Ready for state-of-the-art?

Let's see how we can help.

We are launching an early access program for our Hyperplexed nucleic acid platforms. 

 

Do you have an application where you need to detect multiple DNA/RNA targets with high specificity and sensitivity? Are you resorting to unnecessarily complex and expensive solutions like sequencing today?

 

Let us know more about your application to see how we can help you.
 

AVAILABLE TARGETS

Validated targets
ready to use

PATHOGEN PANEL

SARS-CoV-2 Omicron BA.2.12.1 new

SARS-CoV-2 Omicron BA.4/BA.5 new

SARS-CoV-2 Omicron BA.1
SARS-CoV-2 Omicron BA.2

SARS-CoV-2 Wuhan
SARS-CoV-2 Delta
SARS-CoV-2 Kappa
HCoV NL63
HCoV 223E
HCoV OC43
HCoV HKU1
Influenza A H3N2
Influenza A H1N1
Influenza B Victoria
Influenza B Yamagata
AMR mec-A
AMR Oxa-48
E. coli
S. aureus
P. aeroginosa
RSV-A
RSV-B
Norovirus GI
Norovirus GII

RAPID CUSTOMIZED TARGETS

Did not find your targets of interest? No worries, we will customize

One of the main advantages of our technology is its straight-forward primer design. Whether your application is in cancer diagnostics or environmental analysis, let us know and we will tailor a kit for you.

Let's get started

 

GET EARLY ACCESS

I am interested in:
I can send samples

Thanks for submitting! We will get in touch with you.